Less Airway Inflammation and Goblet Cell Metaplasia in an IL-33-Induced Asthma Model of Leptin-Deficient Obese Mice
Background
Asthma with obesity is a phenotype of severe asthma. Leptin exerts an immunomodulatory effect and its level is increased in obesity. IL-33 is associated with innate immunity and induces type 2 inflammation, and is present in adipose tissue. However, the role of IL-33 and leptin in obesity-associated asthma is not fully understood. We examined the effect of IL-33 on eosinophilic inflammation, goblet cell metaplasia, and airway responsiveness in leptin-deficient obese (ob/ob) and wild-type mice, and examined the effect of exogenous leptin pretreatment.
Methods
In ob/ob and wild-type mice, IL-33 was instilled intranasally on three consecutive days. In part of the animals, leptin was injected intraperitoneally prior to IL-33 treatment. The mice were challenged with methacholine and resistance of the respiratory system (Rrs) was measured using the forced oscillation technique. Cell differentiation, IL-5, IL-13, eotaxin, KC in bronchoalveolar lavage fluid (BALF), and histology of the lung were analyzed. For the in vitro study, NCI-H292 cells were stimulated with IL-33 in the presence or absence of leptin, and MUC5AC levels were measured by ELISA.
Results
Ob/ob mice showed greater baseline Rrs than wild-type mice. IL-33 and IL-33 with leptin did not enhance Rrs challenged with methacholine compared to non-treatment in ob/ob mice, whereas IL-33 with leptin enhanced Rrs in wild-type mice. Ob/ob mice showed less IL-33-induced eosinophil numbers, IL-5, IL-13, eotaxin, and KC levels in BALF and eosinophilic infiltration around bronchi and goblet cell metaplasia than wild-type mice, but leptin pretreatment attenuated these changes in ob/ob mice. MUC5AC levels were increased by co-stimulation with IL-33 and leptin in vitro .
Conclusions
Leptin plays an important role in IL-33-induced inflammation and goblet cell metaplasia in the airway, but obesity per se increases airway hyperresponsiveness independent of inflammation. These results explain some aspects of the pathogenesis of obesity-related asthma.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Due to technical limitations, full-text HTML conversion of this manuscript could not be completed. However, the manuscript can be downloaded and accessed as a PDF.
Posted 28 Sep, 2020
On 09 Nov, 2020
Received 08 Nov, 2020
Received 08 Nov, 2020
On 27 Oct, 2020
On 26 Oct, 2020
Received 19 Oct, 2020
Invitations sent on 05 Oct, 2020
On 05 Oct, 2020
On 23 Sep, 2020
On 22 Sep, 2020
On 22 Sep, 2020
On 22 Sep, 2020
Less Airway Inflammation and Goblet Cell Metaplasia in an IL-33-Induced Asthma Model of Leptin-Deficient Obese Mice
Posted 28 Sep, 2020
On 09 Nov, 2020
Received 08 Nov, 2020
Received 08 Nov, 2020
On 27 Oct, 2020
On 26 Oct, 2020
Received 19 Oct, 2020
Invitations sent on 05 Oct, 2020
On 05 Oct, 2020
On 23 Sep, 2020
On 22 Sep, 2020
On 22 Sep, 2020
On 22 Sep, 2020
Background
Asthma with obesity is a phenotype of severe asthma. Leptin exerts an immunomodulatory effect and its level is increased in obesity. IL-33 is associated with innate immunity and induces type 2 inflammation, and is present in adipose tissue. However, the role of IL-33 and leptin in obesity-associated asthma is not fully understood. We examined the effect of IL-33 on eosinophilic inflammation, goblet cell metaplasia, and airway responsiveness in leptin-deficient obese (ob/ob) and wild-type mice, and examined the effect of exogenous leptin pretreatment.
Methods
In ob/ob and wild-type mice, IL-33 was instilled intranasally on three consecutive days. In part of the animals, leptin was injected intraperitoneally prior to IL-33 treatment. The mice were challenged with methacholine and resistance of the respiratory system (Rrs) was measured using the forced oscillation technique. Cell differentiation, IL-5, IL-13, eotaxin, KC in bronchoalveolar lavage fluid (BALF), and histology of the lung were analyzed. For the in vitro study, NCI-H292 cells were stimulated with IL-33 in the presence or absence of leptin, and MUC5AC levels were measured by ELISA.
Results
Ob/ob mice showed greater baseline Rrs than wild-type mice. IL-33 and IL-33 with leptin did not enhance Rrs challenged with methacholine compared to non-treatment in ob/ob mice, whereas IL-33 with leptin enhanced Rrs in wild-type mice. Ob/ob mice showed less IL-33-induced eosinophil numbers, IL-5, IL-13, eotaxin, and KC levels in BALF and eosinophilic infiltration around bronchi and goblet cell metaplasia than wild-type mice, but leptin pretreatment attenuated these changes in ob/ob mice. MUC5AC levels were increased by co-stimulation with IL-33 and leptin in vitro .
Conclusions
Leptin plays an important role in IL-33-induced inflammation and goblet cell metaplasia in the airway, but obesity per se increases airway hyperresponsiveness independent of inflammation. These results explain some aspects of the pathogenesis of obesity-related asthma.
Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Due to technical limitations, full-text HTML conversion of this manuscript could not be completed. However, the manuscript can be downloaded and accessed as a PDF.